Also trades as: EW.SW (SIX)

$90.82

+0.26 (+0.29%)

Weekly Expected Move ±3.2%

$83 $86 $89 $92 $95

NYSE · Healthcare · Medical - Devices · Tech Score Buy · Power 70 · $52.3B mcap · 569M float · 0.692% daily turnover · Short 45% of daily vol

Credit Risk of going bust: lower than 96% of companies Debt: 1.3% of company value Bonds: none of note held by US funds details ▾

Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.06 (down 99.9%), Edwards Lifesciences Corporation would be worth roughly what it owes.
Total debt $704.4M against a stock market value of $52.35B.
Distance to default 20.47 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $299.4M (short-term plus half of long-term), stock volatility 25.4%; Altman Z 12.76. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE

59.1 / 100

NoneWeakNarrowWide

Primary source: Efficient Scale · ROIC: 17.9% · 5Y Avg: 45.2%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale ★

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. EW has a Narrow competitive edge (59.1/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 17.9% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$101

Low

$104

Avg Target

$110

High

Based on 4 analysts since Jul 23, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 33Hold: 16Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$107.00

Analysts2

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-10-27	Deutsche Bank	—	$103	$104	+1	+14.8%	$90.56
2026-07-28	UBS	—	$94	$110	+16	+32.5%	$83.04
2026-07-24	Piper Sandler	—	$100	$101	+1	+20.5%	$83.82
2026-07-24	Leerink Partners	Mike Kratky	$138	$101	-37	+20.5%	$83.82
2026-07-16	Truist Financial	Richard Newitter	$90	$95	+5	+9.5%	$86.78
2026-07-13	RBC Capital	—	$100	$110	+10	+19.5%	$92.03
2026-07-06	Evercore ISI	—	$93	$100	+7	+7.4%	$93.11
2026-06-30	BTIG	Marie Thibault	$100	$110	+10	+20.6%	$91.18
2026-04-27	Barclays	—	$104	$110	+6	+30.7%	$84.15
2026-04-24	Truist Financial	—	$89	$90	+1	+8.2%	$83.15
2026-04-24	Evercore ISI	Vijay Kumar	$94	$93	-1	+11.9%	$83.12
2026-04-24	BTIG	—	$103	$100	-3	+25.4%	$79.72
2026-04-24	Canaccord Genuity	William Plovanic	$87	$85	-2	+6.6%	$79.72
2026-04-13	Mizuho Securities	—	$105	$95	-10	+22.9%	$77.28
2026-02-11	Truist Financial	Richard Newitter	$92	$89	-3	+15.8%	$76.85
2026-02-11	Goldman Sachs	David Roman	$108	$95	-13	+23.3%	$77.05
2026-02-11	Piper Sandler	—	$98	$100	+2	+29.8%	$77.05
2026-02-04	UBS	Danielle Antalffy	$95	$94	-1	+15.2%	$81.62
2026-01-20	Stifel Nicolaus	—	$105	$110	+5	+30.4%	$84.35
2026-01-20	Piper Sandler	—	$73	$98	+25	+16.2%	$84.35
2026-01-12	UBS	Danielle Antalffy	$92	$95	+3	+13.7%	$83.58
2026-01-12	Robert W. Baird	—	$87	$90	+3	+7.5%	$83.69
2026-01-12	Barclays	—	$103	$104	+1	+22.2%	$85.13
2026-01-09	Goldman Sachs	David Roman	$104	$108	+4	+27.7%	$84.58
2026-01-07	Stifel Nicolaus	Rick Wise	$100	$105	+5	+22.3%	$85.85
2026-01-05	Evercore ISI	—	$88	$94	+6	+11.4%	$84.34
2025-12-18	Wells Fargo	—	$96	$100	+4	+17.9%	$84.84
2025-12-17	Canaccord Genuity	William Plovanic	$89	$87	-2	+2.0%	$85.32
2025-12-16	Robert W. Baird	David Rescott	$88	$87	-1	+4.3%	$83.38
2025-12-08	Barclays	—	$99	$103	+4	+19.5%	$86.19
2025-12-05	UBS	—	$90	$92	+2	+6.3%	$86.58
2025-12-05	RBC Capital	Shagun Singh	$95	$100	+5	+14.5%	$87.33
2025-12-05	Robert W. Baird	David Rescott	$83	$88	+5	+2.6%	$85.78
2025-12-05	Canaccord Genuity	William Plovanic	$84	$89	+5	+3.8%	$85.78
2025-12-05	Wells Fargo	Larry Biegelsen	$80	$96	+16	+11.9%	$85.78
2025-12-05	Stifel Nicolaus	Rick Wise	$85	$100	+15	+16.6%	$85.78
2025-12-05	Truist Financial	Richard Newitter	$87	$92	+5	+7.3%	$85.78
2025-12-04	BTIG	Marie Thibault	Initiated	$103	—	+20.1%	$85.78
2025-11-03	Bernstein	Lee Hambright	$74	$90	+16	+9.2%	$82.45
2025-11-03	UBS	—	Initiated	$90	—	+9.2%	$82.45
2025-11-03	Canaccord Genuity	William Plovanic	$75	$84	+9	+1.9%	$82.45
2025-11-03	Raymond James	Jayson Bedford	$83	$96	+13	+16.4%	$82.45
2025-10-31	National Bank	—	Initiated	$92	—	+11.6%	$82.46
2025-10-31	Goldman Sachs	—	$80	$104	+24	+23.1%	$84.48
2025-10-31	RBC Capital	—	$101	$95	-6	+14.1%	$83.29
2025-10-31	Robert W. Baird	David Rescott	$73	$83	+10	-0.3%	$83.29
2025-10-31	Barclays	—	$80	$99	+19	+18.6%	$83.48
2025-10-29	Jefferies	Matthew Taylor	$70	$98	+28	+19.2%	$82.19
2025-10-28	Truist Financial	—	$82	$87	+5	+4.7%	$83.08
2025-10-27	Truist Financial	—	$78	$82	+4	+1.5%	$80.82

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. EW receives an overall rating of B. Strongest factors: ROA (5/5). Areas of concern: P/E (1/5), P/B (2/5).

Rating Change History

Date	From	To
2026-10-01	B+	B
2026-09-02	B	B+
2026-08-28	B+	B
2026-08-24	B	B+
2026-08-18	B+	B
2026-08-17	B	B+
2026-08-05	C	B
2026-08-03	C-	C
2026-07-25	B+	C-
2026-05-06	C-	B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 65 Grade A+

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

100

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. EW scores highest in Safety (100/100) and lowest in Growth (33/100). An overall grade of A+ places EW among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

12.74

Safe Zone

Piotroski F-Score

6/9

✓ ✓ ✗ ✓ ✓ ✗ ✓ ✗ ✓

Beneish M-Score

-2.66

Unlikely Manipulator

Ohlson O-Score

-10.85

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

AA+

Score: 93.3/100

Trend: Stable

Earnings Quality

75/100

OCF/NI: 1.71x

Accruals: -5.2%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. EW scores 12.74, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. EW scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. EW's score of -2.66 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. EW's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. EW receives an estimated rating of AA+ (score: 93.3/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). EW's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

52.20x

PEG

-0.70x

P/S

8.04x

P/B

4.93x

P/FCF

36.45x

P/OCF

30.37x

EV/EBITDA

30.77x

EV/Revenue

7.48x

EV/EBIT

34.36x

EV/FCF

33.97x

Earnings Yield

1.92%

FCF Yield

2.74%

Shareholder Yield

0.88%

Graham Number

$26.83

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 52.2x earnings, EW is priced for high growth expectations. Graham's intrinsic value formula yields $26.83 per share, 239% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.709

NI / EBT

Interest Burden

1.000

EBT / EBIT

EBIT Margin

0.218

EBIT / Rev

Asset Turnover

0.476

Rev / Assets

Equity Multiplier

1.293

Assets / Equity

ROE

9.5%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. EW's ROE of 9.5% is driven by Asset Turnover (0.476), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

$14.79

Price/Value

6.12x

Margin of Safety

-511.70%

Premium

511.70%

Assessment

Overvalued

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with EW's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. EW trades at a 512% premium to its adjusted intrinsic value of $14.79, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 52.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$90.81

Median 1Y

$88.28

5th Pctile

$50.00

95th Pctile

$155.80

Ann. Volatility

34.2%

Analyst Target

$107.00

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Mr. Zovighian Chief Executive Officer and Director	$1,192,500	$7,167,024	$17,454,255
Mr. Ullem Corporate Vice President, Chief Financial Officer	$807,898	$2,205,238	$6,050,554
Mr. Wood Corporate rporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$635,919	$1,818,499	$4,854,339
Mr. Chopra Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies	$671,042	$1,764,066	$4,695,742
Mr. Bobo Corporate Vice President, Strategy & Corporate Development	$759,783	$1,378,274	$4,223,365
Ms. Brüls Corporate Vice President, EMEACLA	$726,586	$1,020,334	$3,732,107

CEO Pay Ratio

134:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $17,454,255

Avg Employee Cost (SGA/emp): $130,325

Employees: 16,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

16,000

+1.3% YoY

Revenue / Employee

$379,225

Rev: $6,067,600,000

Profit / Employee

$67,094

NI: $1,073,500,000

SGA / Employee

$130,325

Avg labor cost proxy

R&D / Employee

$67,450

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	30.3%	28.9%	29.3%	26.3%	24.8%	26.1%	25.2%	22.6%	22.2%	22.5%	21.6%	21.3%	51.3%	50.1%	48.5%	46.1%	13.8%	10.5%	10.7%	9.5%	9.50%
ROA	19.7%	19.1%	19.7%	18.1%	17.4%	18.1%	17.4%	15.9%	15.9%	15.9%	15.4%	15.4%	37.2%	37.2%	36.7%	35.1%	10.4%	8.0%	8.3%	7.3%	7.35%
ROIC	31.9%	28.1%	28.9%	27.9%	27.7%	27.7%	26.5%	25.2%	24.4%	22.9%	20.8%	20.8%	22.3%	18.6%	18.3%	17.9%	18.8%	19.7%	19.6%	17.9%	17.87%
ROCE	23.5%	22.9%	23.5%	22.4%	21.9%	24.3%	22.9%	19.6%	18.7%	17.5%	16.2%	17.0%	13.8%	13.8%	14.2%	13.5%	13.6%	10.4%	10.6%	11.5%	11.47%
Gross Margin	77.0%	76.6%	77.1%	79.2%	78.7%	78.1%	75.4%	79.1%	78.1%	80.2%	78.2%	78.5%	80.6%	78.9%	78.7%	77.6%	77.9%	78.3%	78.2%	77.6%	77.56%
Operating Margin	31.1%	27.2%	32.5%	31.2%	32.4%	30.4%	27.6%	28.6%	27.9%	28.2%	26.7%	26.3%	25.9%	22.6%	27.9%	28.1%	27.4%	23.6%	31.2%	29.8%	29.84%
Net Margin	26.0%	25.2%	27.9%	29.6%	26.0%	29.5%	23.3%	23.7%	31.0%	29.2%	26.5%	26.2%	2.3%	27.8%	25.3%	21.5%	18.7%	5.8%	23.1%	13.9%	13.89%
EBITDA Margin	33.1%	31.4%	35.7%	36.9%	34.1%	37.2%	30.2%	24.0%	34.1%	31.9%	30.8%	30.8%	31.7%	34.9%	33.3%	26.1%	25.0%	8.5%	30.3%	32.3%	32.29%
FCF Margin	27.7%	26.8%	26.7%	23.5%	19.4%	17.7%	17.9%	12.6%	14.7%	12.0%	4.6%	10.3%	9.4%	5.3%	11.8%	10.7%	13.7%	22.0%	17.3%	22.0%	22.01%
OCF Margin	34.5%	33.1%	32.2%	28.6%	24.4%	22.6%	22.5%	17.3%	19.5%	17.0%	10.3%	16.6%	15.1%	9.9%	15.8%	14.0%	17.3%	26.3%	21.6%	26.4%	26.42%
ROE 3Y Avg	snapshot only																				22.84%
ROE 5Y Avg	snapshot only																				22.96%
ROA 3Y Avg	snapshot only																				17.51%
ROIC 3Y Avg	snapshot only																				28.33%
ROIC Economic	snapshot only																				11.28%
Cash ROA	snapshot only																				12.41%
Cash ROIC	snapshot only																				24.33%
CROIC	snapshot only																				20.28%
NOPAT Margin	snapshot only																				19.39%
Pretax Margin	snapshot only																				21.77%
R&D / Revenue	snapshot only																				16.75%
SGA / Revenue	snapshot only																				33.80%
SBC / Revenue	snapshot only																				2.58%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	48.41	54.47	48.16	40.95	35.37	30.21	33.95	41.43	29.51	33.00	40.83	37.96	9.50	10.48	10.20	11.09	33.38	46.35	42.55	51.99	52.195
P/S Ratio	14.04	15.65	13.83	11.13	9.62	8.54	9.19	10.62	7.90	8.79	11.24	10.68	7.40	8.01	7.69	8.09	7.74	8.17	7.38	8.02	8.038
P/B Ratio	12.91	14.03	12.68	10.03	8.30	7.92	8.45	9.03	6.34	6.96	8.11	7.51	4.13	4.37	4.21	4.36	4.46	4.80	4.50	4.92	4.930
P/FCF	50.76	58.39	51.87	47.27	49.64	48.22	51.29	84.41	53.57	73.51	242.45	103.66	78.59	150.79	65.23	75.64	56.64	37.15	42.68	36.45	36.446
P/OCF	40.67	47.27	42.95	38.92	39.42	37.74	40.79	61.22	40.52	51.66	109.29	64.45	48.94	80.61	48.62	57.84	44.80	31.09	34.23	30.37	30.372
EV/EBITDA	38.01	43.31	38.14	31.98	27.29	23.47	26.33	33.33	24.47	28.69	36.62	32.76	21.41	23.13	21.78	23.90	24.34	33.12	30.64	30.77	30.769
EV/Revenue	13.82	15.50	13.68	10.97	9.42	8.44	9.08	10.46	7.68	8.61	11.05	10.43	6.70	7.41	7.11	7.50	7.21	7.59	6.91	7.48	7.478
EV/EBIT	41.68	47.44	41.74	35.11	29.95	25.69	28.87	36.84	27.00	31.73	40.49	36.05	23.52	25.38	23.80	26.12	26.75	37.32	34.55	34.36	34.362
EV/FCF	49.97	57.83	51.31	46.61	48.63	47.67	50.71	83.20	52.08	72.01	238.26	101.25	71.15	139.49	60.33	70.11	52.73	34.51	39.96	33.97	33.971
Earnings Yield	2.1%	1.8%	2.1%	2.4%	2.8%	3.3%	2.9%	2.4%	3.4%	3.0%	2.4%	2.6%	10.5%	9.5%	9.8%	9.0%	3.0%	2.2%	2.3%	1.9%	1.92%
FCF Yield	2.0%	1.7%	1.9%	2.1%	2.0%	2.1%	1.9%	1.2%	1.9%	1.4%	0.4%	1.0%	1.3%	0.7%	1.5%	1.3%	1.8%	2.7%	2.3%	2.7%	2.74%
Price/Tangible Book	snapshot only																				7.173
EV/OCF	snapshot only																				28.310
EV/Gross Profit	snapshot only																				9.590
Acquirers Multiple	snapshot only																				26.619
Shareholder Yield	snapshot only																				0.88%
Graham Number	snapshot only																				$26.83

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	3.64	3.08	3.41	3.37	3.83	3.03	3.01	3.15	3.28	3.38	3.75	3.71	3.46	4.18	4.45	4.68	4.00	3.72	4.42	4.52	4.522
Quick Ratio	2.87	2.38	2.64	2.60	3.00	2.17	2.17	2.30	2.45	2.62	2.67	2.87	2.89	3.45	3.66	3.87	3.29	3.09	3.63	3.77	3.772
Debt/Equity	0.12	0.12	0.12	0.11	0.11	0.12	0.12	0.11	0.10	0.10	0.10	0.09	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.066
Net Debt/Equity	-0.20	-0.13	-0.14	-0.14	-0.17	-0.09	-0.09	-0.13	-0.18	-0.14	-0.14	-0.17	-0.39	-0.33	-0.32	-0.32	-0.31	-0.34	-0.29	-0.33	-0.334
Debt/Assets	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.07	0.07	0.07	0.07	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.051
Debt/EBITDA	0.37	0.37	0.36	0.37	0.37	0.36	0.36	0.40	0.41	0.43	0.45	0.42	0.42	0.40	0.39	0.39	0.40	0.51	0.49	0.45	0.445
Net Debt/EBITDA	-0.60	-0.41	-0.42	-0.45	-0.57	-0.27	-0.30	-0.48	-0.70	-0.60	-0.64	-0.78	-2.24	-1.87	-1.77	-1.88	-1.80	-2.53	-2.09	-2.24	-2.242
Interest Coverage	234.58	231.00	247.31	293.63	511.42	842.62	1573.64	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity Multiplier	1.47	1.46	1.44	1.42	1.39	1.43	1.45	1.41	1.41	1.41	1.37	1.36	1.36	1.31	1.29	1.28	1.30	1.32	1.29	1.31	1.306
Cash Ratio	snapshot only																				2.820
Cash to Debt	snapshot only																				6.037
FCF to Debt	snapshot only																				2.035
Defensive Interval	snapshot only																				585.2 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.68	0.66	0.69	0.67	0.64	0.64	0.64	0.62	0.59	0.60	0.56	0.55	0.48	0.49	0.49	0.48	0.45	0.45	0.48	0.48	0.476
Inventory Turnover	1.60	1.60	1.66	1.61	1.58	1.46	1.49	1.40	1.34	1.30	1.02	1.11	1.03	1.15	0.99	1.11	1.14	1.20	1.24	1.26	1.262
Receivables Turnover	8.86	9.54	8.76	8.39	8.80	8.79	8.13	7.80	7.88	7.44	6.69	6.82	7.33	7.90	7.45	7.71	8.35	9.57	8.73	8.88	8.876
Payables Turnover	8.01	6.11	8.05	7.84	8.05	5.75	7.19	6.79	6.93	5.94	5.51	5.86	6.06	5.95	6.00	6.89	7.58	6.25	7.84	7.70	7.697
DSO	41	38	42	44	41	42	45	47	46	49	55	54	50	46	49	47	44	38	42	41	41.1 days
DIO	228	228	220	227	230	250	246	260	273	282	357	330	354	318	367	330	320	304	294	289	289.3 days
DPO	46	60	45	47	45	63	51	54	53	61	66	62	60	61	61	53	48	58	47	47	47.4 days
Cash Conversion Cycle	224	206	216	224	227	228	240	253	266	269	346	321	344	303	355	324	316	284	289	283	283.0 days
Fixed Asset Turnover	snapshot only																				3.353
Operating Cycle	snapshot only																				330.0 days
Cash Velocity	snapshot only																				1.531
Capital Intensity	snapshot only																				2.129

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	16.6%	19.3%	19.7%	8.7%	5.3%	2.9%	2.7%	1.3%	-0.3%	-2.2%	-6.6%	-3.6%	-0.2%	3.6%	7.9%	8.8%	10.3%	11.2%	13.8%	14.6%	14.55%
Net Income	86.0%	82.5%	80.8%	-0.5%	-1.3%	1.3%	-3.2%	-4.5%	-1.9%	-7.9%	-5.0%	5.8%	1.9%	2.0%	2.0%	1.8%	-67.2%	-74.4%	-73.8%	-75.8%	-75.75%
EPS	85.8%	82.5%	81.3%	0.0%	-0.1%	3.8%	-0.3%	-2.0%	0.5%	-6.4%	-4.0%	6.9%	2.0%	2.1%	2.0%	1.9%	-66.5%	-74.0%	-73.5%	-75.3%	-75.32%
FCF	1.0%	1.2%	99.3%	20.0%	-26.2%	-32.0%	-31.0%	-45.9%	-24.2%	-34.0%	-75.8%	-21.0%	-36.3%	-53.9%	1.7%	12.9%	60.1%	3.6%	66.8%	1.4%	1.36%
EBITDA	84.7%	77.7%	76.5%	1.1%	0.0%	3.4%	-1.2%	-7.3%	-9.4%	-18.4%	-18.4%	-2.2%	-0.5%	10.6%	16.8%	7.1%	4.4%	-20.4%	-21.5%	-11.2%	-11.24%
Op. Income	26.8%	24.3%	24.9%	5.0%	2.6%	5.6%	0.8%	-1.4%	-7.5%	-13.2%	-14.3%	-11.6%	-6.7%	-6.3%	-0.5%	4.6%	9.5%	17.2%	22.4%	22.9%	22.88%
OCF Growth	snapshot only																				1.16%
Asset Growth	snapshot only																				2.81%
Equity Growth	snapshot only																				0.69%
Debt Growth	snapshot only																				0.26%
Shares Change	snapshot only																				-1.75%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	11.9%	12.0%	11.9%	10.5%	8.9%	7.4%	7.1%	7.9%	7.0%	6.3%	4.7%	2.0%	1.6%	1.4%	1.1%	2.0%	3.1%	4.1%	4.6%	6.3%	6.30%
Revenue 5Y	12.2%	12.0%	11.2%	10.6%	10.1%	9.4%	9.8%	8.9%	8.0%	7.2%	6.1%	5.7%	5.2%	4.6%	4.3%	5.6%	6.1%	6.7%	7.1%	5.7%	5.75%
EPS 3Y	25.8%	28.0%	26.7%	26.8%	24.3%	14.6%	11.8%	23.8%	23.1%	21.0%	20.2%	1.6%	43.8%	43.8%	42.7%	44.8%	-0.1%	-9.4%	-8.3%	-8.6%	-8.58%
EPS 5Y	22.6%	22.2%	19.3%	16.0%	15.3%	20.7%	21.3%	16.0%	14.9%	15.3%	14.3%	16.4%	41.7%	33.9%	32.4%	42.5%	13.1%	7.1%	6.9%	-5.6%	-5.61%
Net Income 3Y	25.3%	27.7%	26.2%	26.2%	23.5%	13.3%	10.4%	23.2%	21.7%	19.4%	18.4%	0.2%	41.2%	40.5%	39.5%	41.7%	-2.2%	-11.1%	-9.8%	-10.2%	-10.24%
Net Income 5Y	21.8%	21.4%	18.6%	15.2%	14.4%	19.6%	20.0%	14.9%	13.8%	14.2%	13.1%	15.2%	40.0%	31.9%	30.4%	41.0%	11.4%	5.4%	5.1%	-7.2%	-7.23%
EBITDA 3Y	16.7%	30.6%	30.6%	27.3%	24.8%	14.8%	11.4%	22.1%	18.7%	14.5%	12.5%	-2.9%	-3.4%	-2.3%	-2.0%	-1.0%	-2.0%	-10.4%	-9.2%	-2.4%	-2.40%
EBITDA 5Y	18.0%	17.1%	15.2%	13.5%	13.0%	11.6%	11.9%	8.6%	7.5%	13.4%	12.4%	13.3%	11.8%	6.4%	5.7%	13.8%	11.7%	5.7%	5.5%	-2.7%	-2.72%
Gross Profit 3Y	12.7%	12.7%	12.5%	12.0%	11.0%	9.7%	9.1%	9.6%	8.3%	7.7%	6.5%	3.3%	2.9%	2.5%	2.2%	2.6%	3.3%	4.0%	4.7%	6.4%	6.40%
Gross Profit 5Y	13.0%	13.0%	12.1%	11.6%	11.2%	10.5%	10.9%	9.9%	8.9%	8.0%	7.0%	6.9%	6.7%	6.2%	5.9%	7.0%	7.1%	7.6%	7.9%	6.4%	6.37%
Op. Income 3Y	15.6%	13.8%	13.6%	13.5%	12.9%	12.5%	9.9%	10.1%	6.4%	4.4%	2.6%	-2.9%	-3.9%	-4.9%	-4.9%	-3.0%	-1.8%	-1.6%	1.4%	4.4%	4.35%
Op. Income 5Y	16.3%	15.3%	13.1%	11.0%	10.8%	10.7%	11.2%	9.9%	7.9%	6.2%	4.8%	5.0%	4.4%	3.0%	2.5%	4.3%	4.2%	4.6%	5.6%	3.3%	3.31%
FCF 3Y	22.6%	27.0%	39.8%	21.4%	8.9%	1.9%	-3.1%	-10.0%	4.6%	-0.9%	-30.7%	-20.0%	-29.1%	-40.9%	-23.0%	-21.6%	-8.2%	11.9%	3.4%	28.1%	28.10%
FCF 5Y	27.9%	23.6%	22.5%	18.4%	9.8%	2.9%	3.7%	-2.4%	0.6%	-1.7%	-14.5%	-5.2%	-9.0%	-20.3%	-9.6%	-8.3%	3.2%	15.6%	8.7%	6.4%	6.41%
OCF 3Y	20.8%	23.2%	30.5%	16.1%	6.9%	1.1%	-3.6%	-9.6%	-0.4%	-5.3%	-22.8%	-15.6%	-22.9%	-32.1%	-20.2%	-19.6%	-8.1%	9.4%	3.1%	22.3%	22.30%
OCF 5Y	23.7%	19.7%	18.9%	15.9%	9.3%	4.0%	3.9%	-0.5%	0.9%	-0.7%	-7.4%	-2.4%	-5.6%	-14.4%	-8.7%	-9.0%	-0.7%	8.6%	3.4%	3.6%	3.58%
Assets 3Y	11.1%	16.9%	15.5%	14.8%	13.1%	8.5%	12.5%	11.9%	11.3%	9.0%	10.5%	9.6%	16.7%	15.4%	15.6%	17.0%	15.4%	18.2%	15.5%	15.5%	15.48%
Assets 5Y	13.5%	13.5%	12.0%	10.4%	9.5%	7.8%	8.2%	9.6%	9.5%	12.0%	12.2%	12.6%	16.8%	15.0%	16.5%	16.0%	14.3%	13.6%	13.1%	12.6%	12.60%
Equity 3Y	18.1%	22.9%	19.2%	19.3%	17.7%	11.9%	15.3%	18.4%	16.5%	13.3%	15.2%	13.2%	19.9%	19.7%	20.1%	21.1%	18.0%	21.2%	20.0%	18.5%	18.53%
Book Value 3Y	18.6%	23.2%	19.7%	19.9%	18.4%	13.2%	16.8%	19.1%	17.9%	14.8%	16.9%	14.7%	22.1%	22.4%	22.9%	23.7%	20.5%	23.5%	22.0%	20.7%	20.73%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.98	0.96	0.95	0.99	0.98	0.95	0.95	0.97	0.93	0.87	0.76	0.77	0.78	0.77	0.61	0.76	0.85	0.88	0.81	0.77	0.767
Earnings Stability	0.64	0.74	0.70	0.71	0.72	0.81	0.80	0.76	0.77	0.69	0.65	0.68	0.64	0.58	0.56	0.58	0.24	0.16	0.16	0.07	0.074
Margin Stability	0.99	0.98	0.98	0.98	0.98	0.97	0.98	0.98	0.98	0.98	0.98	0.98	0.97	0.97	0.97	0.98	0.98	0.98	0.98	0.98	0.984
Rev. Growth Consistency	1.00	1.00	0.50	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.000
Earn. Growth Consistency	1.00	0.50	0.50	0.00	0.00	1.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	0.00	0.00	0.00	0.00	0.000
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.50	0.50	0.50	1.00	0.99	0.99	0.99	0.98	0.99	0.97	0.98	0.98	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.500
Earnings Smoothness	0.40	0.42	0.42	1.00	0.99	0.99	0.97	0.95	0.98	0.92	0.95	0.94	0.02	0.01	0.01	0.05	0.00	0.00	0.00	0.00	0.000
ROE Trend	0.07	0.04	0.03	0.01	0.01	0.04	0.03	-0.05	-0.04	-0.05	-0.06	-0.03	0.21	0.18	0.19	0.19	-0.19	-0.21	-0.20	-0.20	-0.201
Gross Margin Trend	0.02	0.02	0.02	0.03	0.02	0.03	0.02	0.01	0.01	0.01	0.02	0.01	0.02	0.01	0.01	0.01	-0.00	-0.00	-0.01	-0.01	-0.008
FCF Margin Trend	0.10	0.09	0.07	0.02	-0.02	-0.03	-0.03	-0.10	-0.09	-0.10	-0.18	-0.08	-0.08	-0.10	0.01	-0.01	0.02	0.13	0.09	0.12	0.115
Sustainable Growth Rate	30.3%	28.9%	29.3%	26.3%	24.8%	26.1%	25.2%	22.6%	22.2%	22.5%	21.6%	21.3%	51.3%	50.1%	48.5%	46.1%	13.8%	10.5%	10.7%	9.5%	9.50%
Internal Growth Rate	24.6%	23.6%	24.5%	22.1%	21.0%	22.1%	21.1%	19.0%	18.9%	18.9%	18.2%	18.2%	59.3%	59.3%	58.0%	54.2%	11.6%	8.7%	9.0%	7.9%	7.93%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	1.19	1.15	1.12	1.05	0.90	0.80	0.83	0.68	0.73	0.64	0.37	0.59	0.19	0.13	0.21	0.19	0.75	1.49	1.24	1.71	1.712
FCF/OCF	0.80	0.81	0.83	0.82	0.79	0.78	0.80	0.73	0.76	0.70	0.45	0.62	0.62	0.53	0.75	0.76	0.79	0.84	0.80	0.83	0.833
FCF/Net Income	snapshot only																				1.427
OCF/EBITDA	snapshot only																				1.087
CapEx/Revenue	6.9%	6.3%	5.5%	5.0%	5.0%	4.9%	4.6%	4.8%	4.7%	5.1%	5.6%	6.3%	5.7%	4.6%	4.0%	3.3%	3.6%	4.3%	4.3%	4.4%	4.40%
CapEx/Depreciation	snapshot only																				1.732
Accruals Ratio	-0.04	-0.03	-0.02	-0.01	0.02	0.04	0.03	0.05	0.04	0.06	0.10	0.06	0.30	0.32	0.29	0.28	0.03	-0.04	-0.02	-0.05	-0.052
Sloan Accruals	snapshot only																				-0.002
Cash Flow Adequacy	snapshot only																				6.000
Earnings Quality Score	snapshot only																				0.750

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	28.2%	34.1%	40.0%	59.0%	65.6%	1.1%	1.1%	88.0%	90.7%	62.7%	44.6%	53.1%	36.3%	25.4%	31.5%	28.1%	7.9%	13.8%	37.6%	45.6%	45.65%
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.6%	0.6%	0.8%	1.4%	1.9%	3.8%	3.1%	2.1%	3.1%	1.9%	1.1%	1.4%	3.8%	2.4%	3.1%	2.5%	0.2%	0.3%	0.9%	0.9%	0.88%
Net Buyback Yield	0.6%	0.6%	0.8%	1.4%	1.9%	3.8%	3.1%	2.1%	3.1%	1.9%	1.1%	1.4%	3.8%	2.4%	3.0%	2.3%	0.0%	0.0%	0.5%	0.6%	0.58%
Total Shareholder Return	0.6%	0.6%	0.8%	1.4%	1.9%	3.8%	3.1%	2.1%	3.1%	1.9%	1.1%	1.4%	3.8%	2.4%	3.0%	2.3%	0.0%	0.0%	0.5%	0.6%	0.58%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.88	0.88	0.88	0.87	0.87	0.86	0.86	0.90	0.94	0.98	1.01	0.97	2.72	2.69	2.59	2.55	0.87	0.84	0.84	0.71	0.709
Interest Burden (EBT/EBIT)	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.01	0.97	0.97	1.00	0.99	1.03	1.03	1.00	1.000
EBIT Margin	0.33	0.33	0.33	0.31	0.31	0.33	0.31	0.28	0.28	0.27	0.27	0.29	0.28	0.29	0.30	0.29	0.27	0.20	0.20	0.22	0.218
Asset Turnover	0.68	0.66	0.69	0.67	0.64	0.64	0.64	0.62	0.59	0.60	0.56	0.55	0.48	0.49	0.49	0.48	0.45	0.45	0.48	0.48	0.476
Equity Multiplier	1.53	1.51	1.49	1.45	1.43	1.44	1.44	1.41	1.40	1.42	1.40	1.38	1.38	1.35	1.32	1.31	1.33	1.32	1.29	1.29	1.293

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$2.34	$2.38	$2.44	$2.32	$2.34	$2.47	$2.44	$2.28	$2.35	$2.31	$2.34	$2.43	$6.95	$7.07	$7.11	$7.05	$2.33	$1.84	$1.88	$1.74	$1.74
Book Value/Share	$8.77	$9.23	$9.29	$9.48	$9.96	$9.42	$9.79	$10.45	$10.92	$10.96	$11.78	$12.31	$15.96	$16.93	$17.23	$17.94	$17.42	$17.77	$17.78	$18.38	$18.61
Tangible Book/Share	$6.40	$6.87	$6.92	$7.11	$7.67	$7.07	$6.91	$7.61	$8.09	$8.41	$8.97	$9.71	$11.68	$11.93	$12.21	$12.92	$12.47	$12.79	$12.54	$12.61	$12.61
Revenue/Share	$8.06	$8.28	$8.51	$8.54	$8.59	$8.73	$9.00	$8.88	$8.77	$8.68	$8.50	$8.65	$8.92	$9.24	$9.42	$9.67	$10.05	$10.43	$10.86	$11.27	$11.30
FCF/Share	$2.23	$2.22	$2.27	$2.01	$1.66	$1.55	$1.61	$1.12	$1.29	$1.04	$0.39	$0.89	$0.84	$0.49	$1.11	$1.03	$1.37	$2.29	$1.88	$2.48	$2.49
OCF/Share	$2.78	$2.74	$2.74	$2.44	$2.10	$1.98	$2.03	$1.54	$1.71	$1.48	$0.87	$1.43	$1.35	$0.92	$1.49	$1.35	$1.74	$2.74	$2.34	$2.98	$2.98
Cash/Share	$2.84	$2.32	$2.38	$2.42	$2.78	$1.97	$2.05	$2.47	$3.06	$2.69	$2.81	$3.29	$7.43	$6.73	$6.63	$6.91	$6.56	$7.27	$6.32	$7.36	$7.38
EBITDA/Share	$2.93	$2.96	$3.05	$2.93	$2.97	$3.14	$3.11	$2.79	$2.75	$2.60	$2.56	$2.75	$2.79	$2.96	$3.08	$3.03	$2.97	$2.39	$2.45	$2.74	$2.74
Debt/Share	$1.08	$1.09	$1.09	$1.09	$1.10	$1.12	$1.13	$1.12	$1.13	$1.13	$1.16	$1.15	$1.18	$1.19	$1.19	$1.20	$1.20	$1.21	$1.21	$1.22	$1.22
Net Debt/Share	$-1.76	$-1.23	$-1.28	$-1.33	$-1.68	$-0.85	$-0.93	$-1.35	$-1.92	$-1.56	$-1.65	$-2.15	$-6.25	$-5.55	$-5.44	$-5.71	$-5.36	$-6.05	$-5.11	$-6.14	$-6.14

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	12.744
Altman Z-Prime	snapshot only																				24.153
Piotroski F-Score	8	8	8	7	7	6	5	4	4	6	6	5	7	6	7	6	6	6	6	6	6
Beneish M-Score	-2.58	-2.42	-2.45	-2.50	-2.38	-2.29	-2.22	-2.05	-2.08	-2.06	-1.95	-2.16	-1.22	-1.20	-1.33	-1.16	-2.20	-2.45	-2.30	-2.66	-2.660
Ohlson O-Score	snapshot only																				-10.845
ROIC (Greenblatt)	snapshot only																				19.54%
Net-Net WC	snapshot only																				$6.37
EVA	snapshot only																				$556042527.82

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				AA+
Credit Score	95.68	95.87	95.85	96.06	96.18	97.06	95.84	93.88	93.57	93.53	95.07	93.63	93.27	95.21	93.47	93.69	93.38	93.28	92.76	93.26	93.260
Credit Grade	snapshot only																				2
Credit Trend	snapshot only																				-0.434
Implied Spread (bps)	snapshot only																				65.000
Industry Credit Rank	snapshot only																				87
Sector Credit Rank	snapshot only																				90

EW NYSE

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet